T1	Temporal 0 5	Prior
T2	Qualifier 17 32	investigational
T3	Drug 33 49	anti-HIV vaccine
R1	Has_qualifier Arg1:T3 Arg2:T2	
R2	Has_temporal Arg1:T3 Arg2:T1	
T4	Temporal 51 58	Ongoing
T5	Procedure 59 66	therapy
R3	Has_temporal Arg1:T5 Arg2:T4	
T6	Drug 94 118	Systemic corticosteroids
T7	Multiplier 120 132	Short course
T8	Multiplier 133 162	less than or equal to 21 days
T9	Condition 166 181	corticosteroids
T10	Negation 182 192	is allowed
R4	Subsumes Arg1:T7 Arg2:T8	
R5	Has_multiplier Arg1:T9 Arg2:T7	
R6	Has_negation Arg1:T9 Arg2:T10	
T11	Scope 120 192	Short course less than or equal to 21 days of corticosteroids is allowed
T12	Drug 194 226	Systemic chemotherapeutic agents
T13	Drug 228 255	Nephrotoxic systemic agents
T14	Drug 267 282	aminoglycosides
T15	Drug 284 298	amphotericin B
T16	Drug 300 309	cidofovir
T17	Drug 311 320	cisplatin
T18	Drug 322 331	foscarnet
T19	Drug 333 344	pentamidine
T20	Procedure 346 373	Immunomodulatory treatments
T21	Drug 384 397	Interleukin-2
T22	Drug 399 421	Investigational agents
R7	Subsumes Arg1:T20 Arg2:T21	
*	OR T14 T15 T16 T17 T18 T19 T20 T22 T13 T12 T6
R8	Has_scope Arg1:T6 Arg2:T11	
T23	Scope 94 421	Systemic corticosteroids. Short course less than or equal to 21 days of corticosteroids is allowed; Systemic chemotherapeutic agents; Nephrotoxic systemic agents, including aminoglycosides, amphotericin B, cidofovir, cisplatin, foscarnet, pentamidine; Immunomodulatory treatments including Interleukin-2; Investigational agents
R9	Has_scope Arg1:T5 Arg2:T23	
T24	Condition 429 436	allergy
T25	Condition 437 448	sensitivity
T26	Condition 456 472	hypersensitivity
T27	Drug 476 501	components of study drugs
T28	Drug 503 506	ART
R10	Subsumes Arg1:T27 Arg2:T28	
T29	Drug 508 529	or their formulations
*	OR T27 T29
T30	Scope 476 529	components of study drugs (ART) or their formulations
R11	Has_scope Arg1:T26 Arg2:T30	
*	OR T25 T24 T26
T31	Condition 546 557	alcohol use
T32	Condition 554 557	use
T33	Condition 538 542;561 571	drug dependence
T34	Condition 546 553;561 571	alcohol dependence
*	OR T33 T34 T31 T32
T35	Qualifier 577 629	would interfere with adherence to study requirements
T36	Scope 538 571	drug or alcohol use or dependence
T37	Temporal 531 537	Active
R12	Has_temporal Arg1:T36 Arg2:T37	
R13	Has_qualifier Arg1:T36 Arg2:T35	
T38	Condition 650 669	psychiatric illness
T39	Condition 639 646;662 669	medical illness
*	OR T38 T39
T40	Qualifier 631 638	Serious
T41	Scope 639 669	medical or psychiatric illness
R14	Has_qualifier Arg1:T41 Arg2:T40	
T42	Qualifier 675 739	would interfere with the ability to adhere to study requirements
R15	Has_qualifier Arg1:T41 Arg2:T42	
T43	Condition 741 748;758 779	Chronic hepatitis B infection
T44	Condition 752 779	acute hepatitis B infection
T45	Drug 788 812	female hormonal products
T46	Qualifier 822 830;834 845	estrogen derivatives
T47	Qualifier 822 830	estrogen
*	OR T46 T47
T48	Scope 822 845	estrogen or derivatives
R16	Has_scope Arg1:T45 Arg2:T48	
